Cannara Biotech Inc (LOVE.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 08/31
(Values in thousands)
| 08-2020 | 08-2019 | 08-2018 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 7,771 | 26,506 | 12,900 |
| Receivables | 309 | 828 | 585 |
| Inventories | 2,242 | 187 | N/A |
| Other current assets | 0 | 211 | 0 |
| TOTAL | $10,530 | $27,828 | $13,485 |
| Non-Current Assets | |||
| PPE Net | 43,733 | 39,260 | 13,824 |
| Intangibles | 162 | 281 | N/A |
| Other Non-Current Assets | 425 | 734 | 1,551 |
| TOTAL | $44,321 | $40,275 | $15,376 |
| Total Assets | $54,850 | $68,103 | $28,860 |
| Liabilities | |||
| Current Liabilities | |||
| Short Term Debt | 302 | N/A | N/A |
| Accounts payable and accrued liabilities | 2,915 | 4,740 | 1,091 |
| Other current liabilities | N/A | 211 | N/A |
| TOTAL | $3,477 | $5,091 | $1,164 |
| Non-Current Liabilities | |||
| Long Term Debt | 11,981 | 12,526 | 12,509 |
| Deferred Revenues | 50 | N/A | N/A |
| Other Non-Current Liabilities | 75 | -2,764 | 0 |
| TOTAL | $13,009 | $13,084 | $12,954 |
| Total Liabilities | $16,486 | $18,175 | $14,118 |
| Shareholders' Equity | |||
| Common Shares | 58,362 | 54,926 | 15,854 |
| Retained earnings | -27,077 | -14,428 | -2,113 |
| Other shareholders' equity | 46 | -10 | 0 |
| TOTAL | $38,365 | $47,165 | $14,742 |
| Total Liabilities And Equity | $54,850 | $65,339 | $28,860 |